KINTAI Biotech Recognized as National High-tech Enterprise

KINTAI Biotech Inc., a company operating in the biotechnology sector, has officially achieved National High-tech Enterprise status. This recognition, announced on November 6, 2024, signifies the company's adherence to specific criteria regarding research, development, and innovation.

The designation is a notable accomplishment for KINTAI Biotech, which focuses on producing ingredients and raw materials for the dietary supplement and cosmetics industries. The company stated that this recognition reinforces its market position and motivates continued investment in technological advancement.

Recent industry news involving KINTAI Biotech includes the approval of dihydroquercetin as a new food ingredient and research into the neuroprotective benefits of ursolic acid. These developments, coupled with its high-tech enterprise status, position KINTAI Biotech as a company focused on scientific and health-related innovations.

The company's product range includes various compounds and extracts such as CoQ10, L-carnosine, collagen tripeptides, and other bio-active ingredients, catering to the evolving demands of the health and wellness market.